Join our community!

We believe in entrepreneurship in Haifa, and invite you to share a part of our journey

STARTUPS?

Get listed

Service provider?

Join us today

Have an Event?

Submit an event

Stay updated with our news! our newsletter now

SIGN UPTO STAY IN
THE LOOP

Join our newsletter to be updated
on everything that happens in
entrepreneurship field in Haifa

Promise not to send spam!
You can unsubscribe any time

Home / Startups / Pluristem Therapeutics
Pluristem Therapeutics

Pluristem Therapeutics

Placental Cell Therapy to Stimulate Innate Healing Processes

Pluristem Therapeutics Inc is a clinical-stage biotechnology company using placental cells and a proprietary three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases. Pluristem converts human placental cells into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. The companys pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an off-the-shelf product. The companys GMP-certified in-house manufacturing facilities allow it to produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is one of the first companies to manufacture large quantities of placenta-based cell products using a 3D bioreactor.

Sectors: Pharmaceuticals

Year of establishment:

2003

Fundraising stage:

Public

Product/Service stage:

Clinical trial

Number of employees:

51-200

Contact Pluristem Therapeutics

Address

MATAM, Building 5, Haifa 31905

Phone Number

972-74-710-8600
Want some more?